[1] Simpson FE. Radium in skin diseases. JAMA,1913,61:80-83. [2] Owen AK. A case of melanosarcoma treated with roentgen rays. Am J Roentgen,1924,11:335-336. [3] Evans WA,Leucutia T. The treatment of metastatic tumors of the skin: pigmented moles and melanomas. Am J Roentgen,1931,26:236-259. [4] Anderson HF,Simpson CA. Pigmented moles and their treatment. Am J Roentgen,1935,33:54-58. [5] Ellis F. Radiosensitivity of malignant melanomata. Br J Radiol,1939,12:327-352. [6] Hellriegel W. Radiation therapy of primary and metastatic melanoma. Ann NY Acad Sci,1963,100:131-141. [7] Rofstad EK. Radiation biology of malignant melanoma. Acta Radiol Oncol,1986,25:1-10. [8] Konefal JB,Emami B,Pilepich MV. Malignant melanoma: analysis of dose fractionation in radiation therapy. Radiology,1987,164:607-610. [9] Bentzen SM,Overgaard J,Thames HD,et al. Clinical radiobiology of malignant melanoma. Radiother Oncol,1989,16:169-182. [10] Sause WT,Cooper JS,Rush S,et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys,1991,20:429-432. [11] Chang DT,Amdur RJ,Morris CG,et al. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys,2006,66:1051-1055. [12] Balch CM,Buzaid AC,Soong SJ,et al. Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol,2001,19:3635-3648. [13] Guadagnolo BA,Zagars GK. Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol,2009,10:409-416. [14] Burmeister BH,Mark SB,Burmeister E,et al. A prospective phase Ⅱ study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-trans tasman radiation oncology group(TROG) study 96.06. Radiother Oncol,2006,81:136-142. [15] Burmeister BH,Henderson MA,Ainslie J,et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol,2012,13:589-597. [16] Owens JM,Roberts DB,Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg,2003,129:864-868. [17] Temam S,Mamelle G,Marandas P,et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer,2005,103:313-319. [18] Krengli M,Masini L,Kaanders JH,et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A rare cancer network study. Int J Radiat Oncol Biol Phys,2006,65:751-759. [19] Meleti M,Leemans CR,de Bree R,et al. Head and neck mucosal melanoma: experience with 42 patients,with emphasis on the role of postoperative radiotherapy. Head Neck,2008,30:1543-1551. [20] Benlyazid A,Thariat J,Temam S,et al. Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg,2010,136:1219-1225. [21] Moreno MA,Roberts DB,Kupferman ME,et al. Mucosal melanoma of the nose and paranasal sinuses,a contemporary experience from the M.D. Anderson cancer center. Cancer,2010,116:2215-2223. [22] Roth TN,Gengler C,Huber GF,et al. Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck,2010,32:1385-1392. [23] Gilligan D,Slevin NJ. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol,1991,64:1147-1150. [24] Wada H,Nemoto K,Ogawa Y,et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan. Int J Radiat Oncol Biol Phys,2004,59:495-500. [25] Shibuya H,Takeda M,Matsumoto S,et al. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys,1993,25:35-39. [26] Yanagi T,Mizoe JE,Hasegawa A,et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys,2009,74:15-20. [27] Mizoe JE,Hasegawa A,Jingu K,et al. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol,2012,103:32-37. [28] Zenda S,Kawashima M,Nishio T,et al. Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys,2011,81:135-139. [29] Zimmerman LE,Mclean IW,Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol,1978,62:420-425. [30] The collaborative ocular melanoma study(COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma Ⅲ: local complications and observations following enucleation COMS report No.11. Am J Ophthalmol,1998,126:362-372. [31] The collaborative ocular melanoma study(COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma Ⅱ: initial mortality findings. COMS report No.10. Am J Ophthalmol,1998,125:779-796. [32] Hawkins BS,Collaborative ocular melanoma study group. The collaborative ocular melanoma study(COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: Ⅳ. ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol,2004,138:936-951. [33] Diener-West M,Earle JD,Fine SL,et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma,Ⅲ: initial mortality findings. COMS Report No.18. Arch Ophthalmol,2001,119:969-982. [34] Collaborative ocular melanoma study group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: Ⅴ. twelve-year mortality rates and prognostic factors: COMS report No.28. Arch Ophthalmol,2006,124:1684-1693. [35] Melia BM,Abramson DH,Albert DM,et al. Collaborative ocular melanoma study(COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. Visual acuity after 3 years COMS report No.16. Ophthalmology,2001,108:348-366. [36] Macdonald EC,Cauchi P,Kemp EG. Proton beam therapy for the treatment of uveal melanoma in Scotland. Br J Ophthalmol,2011,95:1691-1695. [37] Dunavoelgyi R,Dieckmann K,Gleiss A,et al. Local tumor control,visual acuity,and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys,2011,81:199-205. [38] Toktas ZO,Bicer A,Demirci G,et al. Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications. J Clin Neurosci,2010,17:441-445. [39] Skibber JM,Soong SJ,Austin L,et al. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol,1996,3:118-123. [40] Long GV,Menzies AM,Nagrial AM,et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol,2011,29:1239-1246. [41] Zakrzewski J,Geraghty LN,Rose AE,et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer,2011,117:1711-1720. [42] Fife KM,Colman MH,Stevens GN,et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol,2004,22:1293-1300. [43] Samlowski WE,Watson GA,Wang M,et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery(SRS). Cancer,2007,109:1855-1862. [44] Jensen RL,Shrieve AF,Samlowski W,et al. Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery. Clin Neurosurg,2008,55:150-159. [45] Jagannathan J,Yen CP,Ray DK,et al. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. J Neurosurg,2009,111:431-438. [46] Clarke JW,Register S,Mcgregor JM,et al. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol,2010,33:70-74. [47] Liew DN,Kano H,Kondziolka D,et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg,2011,114:769-779. [48] Knisely JP,Yu JB,Flanigan J,et al. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg,2012,117:227-233. [49] Kocher M,Soffietti R,Abacioglu U,et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol,2011,29:134-141. [50] Rades D,Schild SE. Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? Strahlenther Onkol,2012,188:702-706. [51] Rades D,Heisterkamp C,Huttenlocher S,et al. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys,2010,77:537-541.
2014, Vol. 23 
